SHS News

Tübingen / 26 November 2024 SHS Capital acquires a majority stake in the therapy and rehabilitation home care provider MTR. The aim of the investment is to further grow the core business and support the nationwide expansion that has already been initiated. Medizintechnik Rostock GmbH is a home care provider for therapy devices, founded in […]

Tuebingen / 07.10.2024 SHS Capital is pleased to announce a significant investment alongside its limited partners in one of its portfolio companies, Develco. SHS Capital has been a committed investor since 2020 and is pleased to have offered its LPs the opportunity to co-invest in Develco. Develco is a specialty pharma company focused on the […]

The German Private Equity Investor SHS Capital has completed the Final Closing of its sixth fund generation The targeted fund volume of EUR 200 million could significantly be overachieved with ca. EUR 270 million and is more than doubling the predecessor fund’s size The new fund will invest in European growing healthcare companies and allocates […]

SHS Capital has acquired a majority stake in the Baden-Württemberg-based robotics company ESSERT GmbH ESSERT develops intelligent automation solutions for a wide range of applications with a focus on the pharmaceutical, life science and general industrial sectors The company’s core product is the ESSERT MicroFactory, a modular production platform for the automation of low-volume, high-mix […]

CAM Bioceramics B.V., based in Leiden, the Netherlands, is a leading global manufacturer of innovative calcium phosphate solutions for Medtech and LifeScience applications Together with ING Corporate Investments and several Co-Investors, the German specialist healthcare investor acquires a majority stake in the company, while current owners remain significant shareholders This investment is the third transaction […]

Spiegelberg GmbH & Co. KG is one of the leading suppliers in the field of manufacturing devices and consumables for intracranial pressure measurement and has been able to grow strongly in recent years  Luciole Medical AG, which specialises in cerebral monitoring and measurement of oxygen saturation in the brain, is expanding its product range with […]

SHS partners with the founders of MESI, a fast-growing Slovenia-based diagnostic company growing revenues >50% p.a. in the last 5 years MESI’s cutting-edge technology digitalizes medical assessment, resulting in workflow optimisation, cost saving and improved patient outcomes The investment aims to further accelerate MESI’s growth and global market presence, and help to transform healthcare with […]

SHS invests €10 million euro from its newly launched sixth fund generation into the Zurich-based growth company Simulands AG develops, produces, and distributes innovative simulation devices and tools for cardiovascular interventions The investment aims to further accelerate the commercialisation of the company and help revolutionise cardiovascular education and training through advanced training solutions for physicians […]

Medical technology market in Germany with slight growth in 2021 Pandemic leaves positive as well as negative traces on medical technology companies in second year, with the former predominating SHS expects a good development for medical technology in Germany in 2022 due to the improvement in the pandemic situation The new regulatory requirements (MDR/IVDR) will […]

Blazejewski MEDI-TECH GmbH is one of the technology leaders in the field of complex 2D and 3D endoscopy and has been able to grow very strongly in recent years Reinhold Blazejewski, Founder and Managing Director of Blazejewski MEDI-TECH, also sells part of his shares to the Erbe Group, but remains with the company as a […]

Tübingen / 18.08.2022 Manfred Ulmer-Weber has been appointed to the management board of SHS Gesellschaft für Beteiligungsmanagement mbH. Ulmer-Weber will be jointly responsible for the allocation of the new SHS VI fund of the Tübingen-based sector specialist. The additional Managing Partner is an SHS home-grown and started his career at SHS in 2010. The shareholders […]

SHS Gesellschaft für Beteiligungsmanagement has received capital commitments of over 220 million euros for its sixth fund at the first closing. Faster than expected, the Tübingen-based healthcare investor has already exceeded its target of 200 million euros at the first closing. The sixth SHS fund generation also aims at majority and minority investments in the […]